Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.20
+0.20 (1.11%)
At close: Jun 26, 2026, 4:00 PM EDT
17.84
-0.36 (-1.98%)
After-hours: Jun 26, 2026, 5:50 PM EDT
Avalo Therapeutics Employees
Avalo Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 10 or 43.48% compared to the previous year.
Employees
33
Change (1Y)
10
Growth (1Y)
43.48%
Revenue / Employee
$1,788
Profits / Employee
-$2,567,879
Market Cap
956.69M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| Pharming Group | 407 |
| Kura Oncology | 260 |
| DBV Technologies | 161 |
| Sana Biotechnology | 142 |
| Olema Pharmaceuticals | 137 |
| Alpha Tau Medical | 121 |
| Janux Therapeutics | 108 |
AVTX News
- 2 days ago - Avalo Therapeutics to join Russell 2000, Russell 3000 - TheFly
- 2 days ago - Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 5 days ago - Avalo Therapeutics Appoints Ron Philip to Board of Directors - GlobeNewsWire
- 12 days ago - Avalo Therapeutics advances AVTX-010 - TheFly
- 12 days ago - Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody - GlobeNewsWire
- 16 days ago - Avalo Therapeutics initiated with a Buy at BofA - TheFly
- 26 days ago - Avalo Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Avalo Therapeutics Announces Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire